Does measles immunization lead to immunization for COVID-19? Case series

dc.contributor.authorAkkucuk, Mehmet Husamettin
dc.contributor.authorAkalin, Nalan
dc.contributor.authorGulalp, Betul
dc.contributor.orcIDhttps://orcid.org/0000-0003-4569-1143en_US
dc.contributor.orcIDhttps://orcid.org/0000-0002-2045-2771en_US
dc.contributor.researcherIDAAJ-2828-2021en_US
dc.contributor.researcherIDP-6931-2016en_US
dc.date.accessioned2022-10-05T10:16:40Z
dc.date.available2022-10-05T10:16:40Z
dc.date.issued2021
dc.description.abstractThere are many studies on protective, preventive and treatment methods for about Covid-19 pandemic, which affects the whole world.The results of epidemiological studies also guide these researches. The studies of the scientists who are struggling with this pandemic worldwide reveal that the incidence of covid-19 is low in the child age group and the disease survived more mildly in childhood. There is an opinion about the reason why covid-19 disease is seen less frequently and milder in pediatric patients, that active immunization created with childhood vaccines. For this reason, we compared the Rubeola immunoglobulin levels formed aganist the measles vector, one of the childhood vaccines which has antigenic similarity with the SARS-CoV family, in patients diagnosed with covid-19 in our hospital and Rubeola immunoglobulin levels of screening performed in healthy individuals before pandemi. As a result , we found the measles IgG levels were statistically significantly higher in patients diagnosed with measles IgG covid-19 compared to the control group. According to this result, this significant increase in level after being infected with SARS-CoV2 in patients with measles immunization may have positive effects on the course of the disease. In addition. we saw that all our Covid-19 patients with high measles antibody recovered without serious mortality and morbidity , despite their age, gender and chronic diseases. Therefore , considering the completion process of vaccination studies, we think that measles vaccination can be applied to risky groups without contraindications to reduce the existing destructive effects of the disease.en_US
dc.identifier.endpage123en_US
dc.identifier.issn1839-0188en_US
dc.identifier.issue1en_US
dc.identifier.startpage119en_US
dc.identifier.urihttp://hdl.handle.net/11727/7828
dc.identifier.volume19en_US
dc.identifier.wos000607365000015en_US
dc.language.isoengen_US
dc.relation.isversionof10.5742/MEWFM.2021.93957en_US
dc.relation.journalWORLD FAMILY MEDICINEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectcovid 19en_US
dc.subjectmeasles IgGen_US
dc.titleDoes measles immunization lead to immunization for COVID-19? Case seriesen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: